Last deal

$111.74M

Amount

Post-IPO Equity

Stage

02.08.2022

Date

3

all rounds

$716.14M

Total amount

date founded

Financing round

General

About Company
Axonics Modulation Technologies develops implantable neuromodulation technology for chronic pain and overactive bladder.

Industry

Sector :

Subsector :

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company aims to improve the quality of life for millions of adults globally who suffer from bladder and bowel dysfunction. Axonics offers the Axonics Sacral Neuromodulation System for overactive bladder and fecal incontinence, as well as the Bulkamid hydrogel for women with stress urinary incontinence. Headquartered in Irvine, California, Axonics is dedicated to providing innovative solutions to help those in need.
Contacts

Phone number

Social url

Similar Companies
1000
WISE

WISE

WISE S.r.l. is a start-up that develops stretchable electrodes for neuromodulation therapy.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Milan, Metropolitan City of Milan, Italy

total rounds

7

total raised

$29.7M
Spinal Modulation

Spinal Modulation

Spinal Modulation is a medical device company that develops spinal cord neurostimulator systems for chronic intractable pain.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Menlo Park, CA, USA

total rounds

5

total raised

$111.27M
Symple Surgical

Symple Surgical

Symple Surgical develops therapeutic microwave energy devices to modulate and monitor hyperactive sympathetic nerve signals.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Flagstaff, AZ, USA

total rounds

2

total raised

$399.83K
NeuSpera Medical

NeuSpera Medical

NeuSpera is developing injectable neuromodulation devices.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

San Jose, CA, USA

total rounds

5

total raised

$111.89M
M&A Details
1

Acquired by

Boston Scientific

announced date

08.01.2024

price

$3.7B

Financials

Funding Rounds
10
3

Number of Funding Rounds

$716.14M

Money Raised

Their latest funding was raised on 02.08.2022. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
02.08.2022
$111.74M
14.05.2021
$201.3M
08.05.2020
$130M
Co-Investors
Investors
9
8

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Series C
Yes
Series A, Series C
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

167

count Of Exists

39
Aperture Venture Partners

Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused on investing in the healthcare and healthy living industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital

Location

New York, NY, USA

count Of Investments

43

count Of Exists

12
Legend Capital

Legend Capital

Legend Capital is a leading venture capital investment manager in China focusing on high-growth ventures.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Beijing, China

count Of Investments

424

count Of Exists

9
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Contura acquired by Axonics Modulation Technologies

Contura acquired by Axonics Modulation Technologies

acquirer

Axonics Modulation Technologies
Axonics Modulation Technologies

date

25.02.2021

type

Acquisition

price

$200M
Contura

Contura

Contura is a specialist pharmaceutical company focused on urology and urogynaecology.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Pharmaceuticals, Manufacturing

Location

London, UK

total rounds

2

total raised

$11.11M

People

Founders
1
Guangqiang Jiang
Guangqiang Jiang

Guangqiang Jiang

Dr. Jiang is a seasoned technical executive with a 15-year track record of developing complex, implantable Class III medical devices. He was previously VP of R&D at the Alfred Mann Foundation. Dr Jiang was elected to the American Institute for Medical and Biological Engineering (AIMBE)’s College of Fellows and served as Principal Investigator on several government contracts. Dr Jiang holds a Ph.D. in Biomedical Engineering from the University of Southern California.

current job

Axonics Modulation Technologies
Axonics Modulation Technologies

organization founded

1

Guangqiang Jiang

Employee Profiles
23

Richard Curtis

Vice president, europe

John Sullivan

Territory manager

Rob Angold

Territory manager

Ashley Noghrey

Accounts payable specialist

Tom Guilfoil

Territory manager

Mark Altmann

Area director

Scott Wallace

Territory manager

Sandra Thomson

Senior manager of talent acquisition and leadership development

Activity

Recent News
11
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month